Colin Hardy

1.4k total citations
26 papers, 964 citations indexed

About

Colin Hardy is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Colin Hardy has authored 26 papers receiving a total of 964 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Health, Toxicology and Mutagenesis, 7 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Colin Hardy's work include Carcinogens and Genotoxicity Assessment (7 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Software Engineering Techniques and Practices (3 papers). Colin Hardy is often cited by papers focused on Carcinogens and Genotoxicity Assessment (7 papers), Inhalation and Respiratory Drug Delivery (3 papers) and Software Engineering Techniques and Practices (3 papers). Colin Hardy collaborates with scholars based in United Kingdom, United States and Sweden. Colin Hardy's co-authors include Tom Fahey, Susan M. Smith, Frank Moriarty, Kathleen Bennett, Derek Coombs, J.B. Thompson, Janette R. Cushman, George Cruzan, W. Ray Brown and Larry S. Andrews and has published in prestigious journals such as Advanced Drug Delivery Reviews, Radiology and Journal of the American Geriatrics Society.

In The Last Decade

Colin Hardy

25 papers receiving 910 citations

Peers

Colin Hardy

PRM

HTM

Jamshid Salamzadeh Iran

Felix W. Frueh United States

Elena Tragni Italy

Manuel Morgado Portugal

Jung Mi Oh South Korea

Donald Perrier United States

Jeremiah D. Momper United States

Beverly A. Smith United States

Peter Arlett Netherlands

Jason L. Vassy United States

Jamshid Salamzadeh Iran

Colin Hardy

123 ×0.5

112 ×0.6

PRM

96 ×0.6

26 ×0.2

HTM

18 ×0.1

Citations per year, relative to Colin Hardy Colin Hardy (= 1×) peers Jamshid Salamzadeh

Countries citing papers authored by Colin Hardy

Since Specialization

Citations

This map shows the geographic impact of Colin Hardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Hardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Hardy more than expected).

Fields of papers citing papers by Colin Hardy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Hardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Hardy. The network helps show where Colin Hardy may publish in the future.

Co-authorship network of co-authors of Colin Hardy

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Hardy. A scholar is included among the top collaborators of Colin Hardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Hardy. Colin Hardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Johansson, Isabelle, Alexander P. Benz, Kumar Balasubramanian, et al.. (2023). Outcomes of Patients with a Mechanical Heart Valve and Poor Anticoagulation Control on Warfarin. Thrombosis and Haemostasis. 124(7). 613–624. 2 indexed citations

O’Brien, Kirsty, Rose Galvin, Colin Hardy, et al.. (2018). Quantifying patient preferences for symptomatic breast clinic referral: a decision analysis study. BMJ Open. 8(5). e017286–e017286. 1 indexed citations

Moriarty, Frank, Colin Hardy, Kathleen Bennett, Susan M. Smith, & Tom Fahey. (2015). Trends and interaction of polypharmacy and potentially inappropriate prescribing in primary care over 15 years in Ireland: a repeated cross-sectional study. BMJ Open. 5(9). e008656–e008656. 197 indexed citations

Moriarty, Frank, Colin Hardy, Kathleen Bennett, Susan M. Smith, & Tom Fahey. (2015). Trends in polypharmacy and prescribing appropriateness from 1997 to 2012. 1 indexed citations

Rana, D. N., et al.. (2015). Cytological and electron microscopic findings in a bronchoalveolar lavage sample from a case of pulmonary alveolar proteinosis with radiological correlation. Cytopathology. 27(5). 374–378.

Forbes, Ben, Bahman Asgharian, Lea Ann Dailey, et al.. (2010). Challenges in inhaled product development and opportunities for open innovation. Advanced Drug Delivery Reviews. 63(1-2). 69–87. 94 indexed citations

Alexander, David J., Christopher J. Collins, Derek Coombs, et al.. (2008). Association of Inhalation Toxicologists (AIT) Working Party Recommendation for Standard Delivered Dose Calculation and Expression in Non-Clinical Aerosol Inhalation Toxicology Studies with Pharmaceuticals. Inhalation Toxicology. 20(13). 1179–1189. 162 indexed citations

Thompson, J.B. & Colin Hardy. (2003). Use and evaluation of SWEBOK by postgraduate students. 11. 66–77. 4 indexed citations

Cruzan, George, Janette R. Cushman, Larry S. Andrews, et al.. (2001). Chronic toxicity/oncogenicity study of styrene in cd‐1 mice by inhalation exposure for 104 weeks. Journal of Applied Toxicology. 21(3). 185–198. 107 indexed citations

10.

Brock, William J., et al.. (1999). Inhalation toxicity and genotoxicity of hydrochlorofluorocarbon (HCFC)-225ca and HCFC-225cb. Journal of Applied Toxicology. 19(2). 101–112. 2 indexed citations

11.

Hardy, Colin, et al.. (1999). The Wicked Relationship between Organizations and Information Technology. Journal of Organizational and End User Computing. 11(4). 40–51. 6 indexed citations

12.

Cruzan, George, Janette R. Cushman, Larry S. Andrews, et al.. (1998). Chronic Toxicity/Oncogenicity Study of Styrene in CD Rats by Inhalation Exposure for 104 Weeks. Toxicological Sciences. 46(2). 266–281. 87 indexed citations

13.

Hardy, Colin. (1997). Twenty-Eight-Day Repeated-Dose Inhalation Exposure of Rats to Diethylene Glycol Monoethyl Ether. Fundamental and Applied Toxicology. 38(2). 143–147. 9 indexed citations

14.

Hardy, Colin, et al.. (1995). A comparison of the results of two surveys on software development and the role of CASE in the UK. 234–238. 1 indexed citations

15.

Farr, Craig H., et al.. (1995). Evaluation of the genotoxicity potential and chronic inhalation toxicity of 1,1-dichloro-1-fluoroethane (HCFC-141 b). Food and Chemical Toxicology. 33(6). 491–500. 11 indexed citations

16.

Hardy, Colin, J.B. Thompson, & Helen M. Edwards. (1995). The use, limitations and customization of structured systems development methods in the United Kingdom. Information and Software Technology. 37(9). 467–477. 56 indexed citations

17.

Kenny, Thomas J., et al.. (1995). Iodotrifluoromethane and Iodoheptafluoropropane Assessment of Cardiac Sensitisation Potential in Dogs.. 1 indexed citations

18.

Bottomley, Paul A., Robert G. Weiss, Colin Hardy, & Werner A. Baumgartner. (1991). Myocardial high-energy phosphate metabolism and allograft rejection in patients with heart transplants.. Radiology. 181(1). 67–75. 47 indexed citations

19.

Bottomley, Paul A., Colin Hardy, Joseph P. Cousins, Megan Armstrong, & William A. Wagle. (1990). AIDS dementia complex: brain high-energy phosphate metabolite deficits.. Radiology. 176(2). 407–411. 31 indexed citations

20.

Hardy, Colin, et al.. (1989). Comparative inhalation toxicity of technical chlordane in rats and monkeys. Journal of Toxicology and Environmental Health. 28(3). 327–347. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact